FBIO (Fortress Biotech) EPS (Basic): $3.84 (TTM As of Mar. 2026)

What is Fortress Biotech EPS (Basic)?

Fortress Biotech FBIO -1.26% 44 EPS (Basic) is $3.84 as of Mar. 2026. GuruFocus rates FBIO with a GF Score™ of 44/100 and a GF Value™ of $1.23 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Fortress Biotech's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was $3.44. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was $3.84.

Fortress Biotech's EPS (Diluted) for the three months ended in Mar. 2026 was $2.82. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $3.15.

Fortress Biotech's EPS without NRI for the three months ended in Mar. 2026 was $-0.99. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was -1.56.

During the past 3 years, the average EPS without NRI Growth Rate was 41.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Fortress Biotech's highest 3-Year average EPS without NRI Growth Rate was 52.10% per year. The lowest was -58.30% per year. And the median was 7.40% per year.

Fortress Biotech (NAS:FBIO) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Fortress Biotech EPS (Basic) Related Terms

Fortress Biotech EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Fortress Biotech's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fortress Biotech EPS (Basic) Chart

Fortress Biotech Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

EPS (Basic)

Get a 7-Day Free Trial

-11.85

-15.97

-8.47

-2.69

-0.07

Fortress Biotech Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
EPS (Basic)	Get a 7-Day Free Trial															-0.48	0.50	0.13	-0.23	3.44

44GF Score

Fortress Biotech Inc FBIO

EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Fortress Biotech EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Fortress Biotech's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(6.815	-	8.697)	/	27.902
	=	-0.07

Fortress Biotech's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(110.373	-	2.008)	/	31.541
	=	3.44

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.84

Frequently Asked Questions Learn more about EPS (Basic) →

What does a EPS (Basic) of $3.84 mean?

Fortress Biotech (FBIO) has a EPS (Basic) of $3.84 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Fortress Biotech and its competitors.

Is Fortress Biotech's EPS (Basic) too high?

Fortress Biotech's current EPS (Basic) is $3.84. Overall, Fortress Biotech has a GF Score™ of 44/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Fortress Biotech's EPS (Basic) compare to PTHS and IBIO?

Fortress Biotech's EPS (Basic) of $3.84 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EPS (Basic) for a Biotechnology company?

A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EPS (Basic) mean?

A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Fortress Biotech and its competitors. Fortress Biotech's current EPS (Basic) is $3.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Fortress Biotech stock overvalued right now?

Based on GuruFocus' analysis, Fortress Biotech (FBIO) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.23, compared to a current price of $3.14 — trading 155.3% above its estimated fair value. The current EPS (Basic) is $3.84. Fortress Biotech's overall GF Score™ is 44/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EPS (Basic) calculated?

EPS (Basic) is calculated from a company's financial statements. For Fortress Biotech (FBIO), the current EPS (Basic) is $3.84 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fortress Biotech (FBIO) Overvalued in 2026?

Based on GuruFocus' analysis, Fortress Biotech stock appears to be overvalued. The current stock price of $3.14 is trading 155.3% above its estimated GF Value™ of $1.23. GuruFocus considers Fortress Biotech to be Significantly Overvalued.

Key valuation signals for FBIO:

EPS (Basic): $3.84
GF Value™: $1.23 vs. price of $3.14 (155.3% above fair value)
GF Score™: 44/100 with 7 warning signs

No single metric tells the full story. See the FBIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fortress Biotech Business Description

Industry Healthcare Biotechnology

Comparable Companies PTHS IBIO NRXS ATRA ICCC RNTX OSTX LONA PYPD ANIX VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Other Exchanges FBIOP.PFD:USA CNB0.PFD:Germany

Address 1111 Kane Concourse, Suite 301, Bay Harbor Island, FL, USA, 33154

Website https://www.fortressbiotech.com

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.

44GF Score

Get the complete analysis for FBIO

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.14

Price

$1.23

GF Value

View FBIO Analysis

See EPS (Basic) data for all stocks →